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Summary findings
Filmer and Pritchett use cross-national data to examine  than one-tenth of 1 percent of the observed differences
the impact on child (under 5) and infant mortality of  in mortality across countries.
both nonhealth  (economic, cultural, and educational)  The estimates imply that for a developing country at
factors and public spending on health. They come up  average income levels, actual public spending per child
with two striking findings:  death averted is $50,000 to $100,000.  This contrasts
* Roughly 95 percent  of cross-national variation in  markedly with a typical range of estimates for the cost-
mortality can be explained by a country's  per capita  effectiveness of medical interventions  to avert the main
income, the distribution  of income, the extent of  causes of child mortality of $10 to $4,000.
women's education, the level of ethnic fragmentation,  They outline three possible explanations for this
and the predominant religion.  divergence between the actual and apparent potential of
* Public spending on health has relatively little impact,  public spending: the allocation of public spending, the
with a coefficient that is numerically small and  net impact of additional public supply, and public sector
statistically insignificant at conventional levels.  efficacy.
Independent  variations in public spending explain less
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In 1995  over 9 million  children  under  five in developing  countries  died avoidable  deaths.
This staggering  figure  is more than  the entire population  of Sweden  or of Zambia. 2 The
cumulative  human  suffering  in the individual  and familial  tragedies  behind  these statistics  is
overwhelming  and creates  a powerfiul  impetus  to action, to do something. This is a laudable
impulse  but if the desire to do something  is allowed  to be the enemy  of good policy  the result can
be wasted,  and possibly  counter-productive,  efforts. In this paper we examine  cross national
differences  in the widest  and best measured  indicators  of health status: child (under-5)  and infant
mortality. We establish  two major points  about the cross national  relationship  between  health
status  and public  spending  on health. 3
First, the differences  across  countries  in infant  and child mortality  are overwhelmingly
explained  by economic  and social factors,  that is, "development"  broadly  taken. The finding  that
I We would  like to thank  Nancy Birdsall,  Jeffrey  Hammer,  Maureen  Lewis,  Samuel
Lieberman,  and Martin  Ravaillon  for helpful  discussions. The findings, interpretations,  and
conclusions  expressed in this paper are entirely those of the authors. They do not necessarily
represent  the views of the World Bank, its Executive  Directors, or the countries  they
represent.  The paper should  not be cited without  the permission  of the authors.
2  "Avoidable"  deaths are defined  as the excess  of the average  death rate for the 0-5 age
group in the low- and middle-income  countries  of 88 per 1000  versus the level in the high-
income  countries,  9. Using a similar  approach  Gwatkin  (1980)  calculated  the total number  of
deaths of under  fives to be about 15  million.
I We use the perhaps  awkward  phrase  "public  spending  on health" throughout  to avoid
the ambiguity  in the phrase  "public health  expenditures"  which  could mean either  "expenditures
on those  items classified  as 'public health"' or "all health  expenditures  by the public  sector."
2"development"  is strongly  associated  with improvements  in mortality  is neither  surprising  nor
new (Caldwell,  1986, World  Bank 1993). What is perhaps  surprising  is the strength  of the
relationship  as essentially  all (95 percent)  of the cross national  variations  in either  under-5  or
infant  mortality  can be explained  by five factors:  the level of income and its distribution,  the
extent of female  education,  the extent of ethnolinguistic  differences  within a country,  and
whether  it is predominately  Muslim. While  there are poor countries  with exceptionally  good
health status,  properly  accounting  for determninants  besides income  reduces  the unexplained
differences  in health  outcomes  and leaves little  to be explained  by independent  variations  in
health  policy.
Second,  there is an enormous  gap between  the apparent  potential of public  spending  to
improve  health  status and the actual  performance. Reviews  of the cost effectiveness  of
preventive  and primary  curative  interventions  suggest  that a significant  fraction  of under five
deaths  could be avoided  for as little as SI  0, and in many cases  under $1000,  per death averted
(Jamison  and others, 1993).  However,  differences  in public  spending  on health account  for
essentially  none (0.15 percent)  of the cross-national  differences  in health status. The extremely
small  actual impact  of public spending  that we estimate from the cross-national  data implies  that
the typical  public  spending  on health  per child death averted  is $50,000  to $100,000,  a striking
discrepancy  between  the apparent  potential  and actual  performance.
Why is public  spending  on health  ineffective  at improving  health  status even though
relatively  cheap  and effective  medical  interventions  exist? Addressing  that complicated  question
in detail is left to a companion  paper  (Filmer, Hammer,  and Pritchett, 1997)  and here we only
suggest  three likely explanations:  (1) cross-national  differences  in the efficacy  of the public
3sector  mean that public spending  on health  does not always translate  into a larger supply  of
effective  health  services,  (2) the impact  of a greater  supply  of effective  health  services  in the
public  sector  on health status  depends  on individual  demand and market supply,  and (3) public
monies  are spent  on expensive,  but ineffective,  curative  services.
I) Explaining  cross-national  variation  in health  status
Much of the intuitive  appeal  behind  many proposed  strategies  to improve  health status,
such as Primary  Health  Care (PHC)  or a "basic package"  of cost-effective  services,  comes from
the simple  but powerful  observation  that there are countries  with exceptionally  good health status
for their level of income  (World  Bank, 1  997a). The relatively  good health  of Sri Lanka,  China,
Costa  Rica, and Kerala,  India is frequently  cited as an indication  of the potential  benefits  from
PHC. 4 However,  it is impossible  to jump from some  countries' good health  outcomes  to the
conclusion  that all (or even that  any) of the unexplained  differences  in mortality  are due to health
policy. While  it is possible  that  these countries' good health outcomes  is due to health  sector
strategy,  it is equally  plausible  that  they share  non-health  characteristics  like  high levels of
female  education  (King and Hill, 1992),  better  nutrition,  more equal income  distribution  (Bidani
and Ravallion, 1997)  that explain  their better outcomes.
To assess the maximum  amount  of the variation  in health  outcomes  that can be explained
by independent  variations  in health sector  expenditures  or policy,  and so properly  identify  the
"outliers,"  we estimate a multivariate  regression  that explains  health outcomes  without  any
' These  countries  (regions)  were highlighted  at a conference  sponsored  by the
Rockefeller  Foundation  (Halstead  et al, 1985).
4health  sector variables:
Health  Status, =f(Incomej,  Female  Education,,  Income Distribution;,  Z,)
where  Z refers  to a vector  of additional  country  specific  non-health  related  variables.
At this stage we resolve  the problem  of attribution  of effects in a multivariate  regression
by assuming  that our non-health  factors  may  cause better health  policy but that better health
policy  does not independently  affect  the included  factors. That is, we assume  more female
education  might lead to better health  policy  but not vice versa. This means we attribute  to female
education,  for example,  both whatever  health  improvements  it may cause directly  through
behavioral  changes  and whatever  indirect  impact  it may have through  better  health policy. This
assumption  about  the causal  ordering  of health  policy  and non-health  factors  is seems reasonable
for nearly  all of the variables  and we return  to the only problematic  case of the  joint
determination  of health status  and income  below.5
The child mortality  figures  used are from a UNICEF  publication  (UNICEF,  1992).6
While  there are difficulties  with measuring  child mortality,  it is arguably  superior  to alternative
measures. Life expectancy  is not reliably  measured  in many countries  and many of the figures
reported  in official  sources  are not based  actual data, but are extrapolations  from child mortality
and assumed  life tables. More comprehensive  measures  of health status that go beyond  mortality
5  While there are a number of difficult details about the data and the empirical
estimation  of this equation  we will not deal in detail with them here, as its main purpose is to
place a (possibly  quite strict) upper bound  on the magnitude  of the health variation across
countries that can be attributed  to differences  in health care strategies (see appendix 1 for the
details on the data).
6Based on background  work done by demographer  Ken Hill (see United  Nations, 1992).
S(such as QALYs  or DALYs)  are even less solidly  based  for cross-national  comparisons. Infant
mortality  is perhaps  more reliably  measured,  but fails  to capture mortality  from many of the
health  conditions  of concem  which  are responsive  to health care, such as diarrhea  and respiratory
infections. Especially  at moderate  to low levels,  infant mortality  is dominated  by perinatal
mortality.
The first empirical  result is the variation  in mortality  associated  with income.  Column I
of Table 1 shows  that a large part of the variation  in (the natural log of) under-5  mortality  can be
"explained"  by (the natural  log of) GDP per capita  and a set of region dummy  variables  only. 7'
Even  excluding  the regional  dummy  variables,  84 percent of mortality  differences  can be
"explained"  by income  alone.
The second,  even more striking,  result in column  2 of Table 1, is that when a few other
variables  are included  over 94 percent  of the variation  in the under-5  mortality  rate is explained.
The level of female  education,  an estimate  of the income  distribution,  a binary  variable  for
whether  the population  of the country is predominantly  Muslim,  and the degree  of
"ethnolinguistic  fractionalization"  are each statistically  significant  and of plausible  sign and
magnitude. 9
' Dummy  variables  are based  on World  Bank  regions:  East Asia and Pacific,  Latin
America  and Caribbean,  Middle  East and  North Africa,  South  Asia, Sub-Saharan  Africa,  and
(excluded  from the regression)  "Rest of World."
8 In order  to ensure the robustness  of these, and subsequent  regressions  (except  the
median  regression),  the two observations  with the largest  impact  on the parameter  vector  are
dropped  from the sample.
9When female  education, income inequality,  ethnolinguistic  fractionalization,  or access
to safe water are missing, the variable is set to zero and a dummy variable  equal to one is
6Table 1: Dependent  variables:  Under-5  mortality  rate  (natural log), 1990.
Column:  I  2  3  4
Dependent  variable  Under-5  Mortality  Rate  Infant  M.R.
Method  OLS  OLS  Two-stage  least  Two-stage  least
squares  squares
GDP per capita (In)  -.661  -.598  -.645*  -A62r
(10.04)  (9.28)  (3.48)  (2.78)
Female  education  -.102  -.098  -.067
_______________  (4.03)  (3.73)  (2.46)
Income  inequality  .012  .013  .003
(2.26)  (2.08)  (.505)
Percent  urban  .003  .004  .001
(1.12)  (.990)  (.292)
Predominantly  Muslim  .408  .399  .199
(3.13)  (2.85)  (1.53)
Ethnolinguistic  .625  .626  .314
fractionalization  (4.14)  (4.20)  (2.12)
Tropical  country  -.006  -.004  -.046
(.063)  (.043)  (.478)
Access to safe water  -.003  -.002  -.003
(1.16)  (-.777)  (1.44)
Additional  variables  Dummy  variables  Dummy  variables  for area and a constant  term. Dummy
for area and a  variables  for when female  education,  income inequality,
constant  term.  ethnolinguistic  fractionalization,  or access to safe water are
missing.
R-Squared  .9023*  .9454r  .9452  .9369
Number  of observations  109  104  104  104
Notes:  White  heteroskedasticity-corrected  t-statistics  are in parentheses.  Countries  with  largest influence  on
parameter  vector  on OLS  case and hence  dropped  are for column  (I) Hong Kong and Turkey,  for columns  (2)
and (3) Rwanda  and Korea  (South),  and for column  (4) Sri Lanka  and Turkey.
*When  dummy  variables  for area are excluded,  the R-squared  for column  (1) is equal to .8534.
Instruments  are, whether  or not the country's main  export is oil, and years  since 1776  that the country  has been
independent.
included  in the regression. Of the 104  countries included  in the regression  in column 2 of
Table 1, 61 are not missing  any of these variables, and 16 are missing  only the inequality
variable.
7The high explanatory  power  of these regressions  is even more  impressive  when one
considers  the role of measurement  error,  both in mortality  and in the independent  variables.
Imagine  the hypothetical  case  that one was "explaining"  an individual's height  with a measure  of
height  taken one minute later. If both measures  were completely  accurate  to the recorded
significant  digits  the regression  R-squared  would  be 1,  but if there were random  error in the first
measurement  with variance  a,2 then the R-squared  would  be I - a, 2 / ( ay2 +  av2 ) where ay2  is the
true variance  of height in the sampled  population.
In the case  of child mortality  we can use a recent compilation  of mortality  estimates  to
gauge  the degree  of measurement  error as there are multiple  estimates  for the same country  for
the same year (United  Nations, 1992). The differences  across  estimates  using different  surveys
and different  methods  for the same periods  are substantial: the four estimates  of child mortality
per 1000  in Egypt in 1980  are 203, 167, 171,  and 97, the four estimates  for Ghana in 1975  are
187,  171, 130  and 125. The average  coefficient  of variation  of these different  measurements  for
a sample  of countries  with repeated  measurements  is 0.129 compared  to a coefficient  of variation
for the sample  as a whole of 0.880,  which would  suggest  the maximum  achievable  R-squared,  if
all the true variation  were explained,  of 0.978.'° The effect  of measurement  error in the
independent  variables  has a similar  effect  in lowering  the feasible  R-squared."
'° We use the coefficient  of variation  since the mean of the small sample for which  we
have  repeated  measurements  is much larger (142) than  the mean across  all countries  (87).
" At low levels, measurement  error in the dependent  and independent  variables are
roughly additive  in lowering  the R-squared.
8Many researchers  do not trust cross-national  comparisons  because  they  doubt the data are
sufficiently  reliable (Srinivasan,  1994). While  it is true that there are difficulties  in accurately
measuring  child mortality,  incomes,  and educational  levels  across countries,  this cannot  be an
explanation  for a high degree  of explanatory  power; the more strongly  one believes  the data is
"bad" the more  puzzling  is the high explanatory  power  of the regression.
In addition  to the high explanatory  power,  the regression  is impressive  as the direction
and magnitude  of the estimates  on the variables  are consistent  with aggregate  and household
results  elsewhere. The estimated  elasticity  of mortality  with respect  to income  of around  -0.6 is
consistent  with what has been found elsewhere,  either  using cross-sectional  or time series
evidence. Kakwani  (1993)  uses functional  forms that allow for varying  income  elasticity  in
cross-national  data and finds a range of elasticities  between  -0.5 and -0.6. Pritchett  and Summers
(1996)  use time series  on changes  in income  and under-S  mortality  from 1960  to 1980  and find
the long-run  elasticity  to be between  -0.43 and -0.76 (depending  on the instruments  used in the
instrumental  variables  estimation). Pritchett  (1997)  uses  time-series  of 22 countries  with data
going back  to 1870  to do fixed  effects  estimation  and finds an infant mortality  elasticity  with
income  of-0.59.  Jamison,  Wang,  Hill and Londono  (1996)  combine  cross section  and time
series  data and find an income  elasticity  of-.65 in 199012. Anand  and Ravallion  (1993) find that
average  income  does have an important  impact  on health  status, but that it operates  only through
its effect  on the share of the population  in poverty  (less than a --1985 PPP-- dollar  a day) while
12 They allow the income  elasticity  to vary across  periods  and find that the estimate
increases  from -.40 in 1960  to -.65 in 1990.
9we find that adding  an estimate  of the proportion  of population  in poverty leaves  our income
estimate unaffected.' 3
In interpreting  estimates  of the impact  of income  on health there is a potentially  serious
econometric  problem  of reverse  causation,  as better  health status might cause higher average
income. This is related  to the problem of the attribution  of effect  between income  and health
policy,  as better  policy  might cause  better health  which  might lead to higher income. While it is
almost  certainly  true that better health  leads to higher income at the individual  level (Strauss  and
Thomas, 1995),  the effect  is less clear at the aggregate  level. Moreover,  it is unlikely  that the
mortality  rate of children  under five would  effect  higher incomes contemporaneously. Pritchett
and Summers  (1996),  using instrumental  variables  and fixed  effects  estimation  on a panel of data
show  that wealthier  is causally  healthier  for the cases  of infant mortality,  under-5  mortality,  and
life expectancy. While  not going  to the same  level of detail in the estimation,  we use two-stage
least squares  estimation  (column  3 of Table 1) using as instruments  for income  whether  or not a
country's primary  export is oil, and the percentage  of years since 1776  that a country  has been
independent.  Other  than the much larger standard  errors the results are largely  unaffected,
suggesting  that whatever  role health  might have in causing  higher incomes it does not affect  the
estimation  of the cross-national  impact  of income  on child mortality.
The results  on female  education  are consistent  with both aggregate  and household  level
studies (King  and Hill, 1993,  Subbarao  and Raney,  1995,  Caldwell 1986, 1990,  and Hobcraft,
13 In any case,  the difference  in the two results  is not about  whether income  affects  health
status-  but about  the particular  functional  form of the specification  for estimating  the income
effect.
101983). Table  2 presents  the differences  in under-5  mortality  by educational  status of the mother
derived  from forty-five  Demographic  and Health  Surveys  which imply that, for the average  of
this sample,  mothers  who have  secondary  schooling  in addition  to primary schooling  (with
usually  about four years  between  levels)  have child mortality  rates 35.8 percent lower. Our cross
country  results, where  mean female  schooling  is 4.97 years,  imply increasing  female  schooling
by 4 years would  lead to 39.2  percent  fall in under-5  mortality.
Table  2: Mean  (standard  deviations)  under-5  mortality  by education  level  of the mother:  DHS results
Mothers  Mothers  Change  Mothers  with  Change  Number  of..
with no  with  (percent)  secondary  (percent)  countries
schooling  primary  schooling
schooling
East Asia and  119.0  69.9  41.3  39.2  43.9  3
Pacific  (40.3)  (18.1)  (16.0)  ___
Latin  America  and  110.9  79.3  28.5  49.4  37.7  10
Caribbean  (52.5)  (43.1)  (26.1)
Middle  East  and  94.5  62.1  34.3  41.4  33.3  6
North Africa  (34.3)  (14.7)  (15.6)
South  Asia  127.7  84.8  33.6  70.9  16.4  4
(41.5)  (29.9)  (22.9)
Sub-Saharan  Africa  179.8  139.9  22.2  87.5  37.5  22
(60.8)  (43.0)  (24.0)
All  144.4  106.5  26.2  68.4  35.8  45
(62.8)  (49.9)  . (30.1)
Notes:  Compiled  from a set of DHS Final  Reports  from 1987  to 1995. Where  there was a choice,  the value for
"4completed  primary"  and/or "completed  secondary"  was chosen. In other  cases the group  may include
mothers  who have  attended  but not completed  the educational  level.
Income  inequality  and ethnolinguistic  fractionalization  are each associated  with worse
under-5  mortality. Flegg (1982)  finds that the elasticity  of infant mortality  with respect  to the
Gini coefficient  is 0.77 when female  illiteracy  is controlled  for. Our results  suggest  that the
11elasticity  is equal to 0.51 at mean income  inequality. Our estimates  imply that a country  with the
high inequality  of Brazil (Gini  of .596) compared  to that of Sri Lanka  (Gini  of .301) could expect
mortality  to be 38 percent lower.
While  it might appear  that the cumulative  empirical  evidence  of a redistributive  impact
on mortality  is weaker  than that of the level of income  or female  education,  this is merely
because  reliable  data on income  distribution  are scarce  and recent. Nearly  all estimates  of the
relationship  between  mortality  and income  use non-linear  functional  forms which  imply a
redistribution  from rich to poor would  increase  the average  level  of mortality. For instance,
Bidani  and Ravallion  (1997)  estimate  the level (not the log) of life expectancy  and infant
mortality  on a non-linear  functional  form for income  that allows different  elasticities  for the poor
and the non-poor  and find strong confirmation  of different  impacts. The rejection  of a linear
functional  form constitutes  powerful  evidence  that income  distribution  matters.
Second,  in estimating  a functional  form that is non-linear  in income  with aggregate  data
the specification  of the relationship  itself implies  that an income  inequality  term must be
included  or else the regression  is mis-specified. For instance,  our estimates  are typical  in
estimating  a relationship  between  the log of average  mortality  and the log of average  income.' 4
But the aggregate  data are averages  of individual  data and the log of average  income is not the
same  as the average  of log incomes  and the difference  between  these two grows as the variance
14 A variety  of non-linear  specifications  have  been used in this literature,  sometimes  a
logistic form is imposed  on mortality  as the dependent  variable  with income in logs, sometimes
just income  is in logs, sometimes  other non-linear  specifications  in income  are used (e.g.
quadratic).
12of income  grows." 5 Therefore,  if the non-linear  functional  form assumed  for aggregates  also
holds in the individual  level data (and there is no reason to assume  that the form of the
relationship  between  income  and mortality  within countries  is different  than the form across
countries)  then this implies that  a measure  of the distribution  should necessarily  be included  in
the regression.'6
The fact that a country  is predominantly  Muslim  is significantly  positively  associated
with higher under-5  mortality,  a result  that has been suggested  previously  in the literature.
Caldwell  (1986) finds  that no exceptionally  good infant mortality  health  performers  relative  to
income  are predominantly  Islamic,  whereas  many  of the poor performers  are. In our results, the
coefficient  on "predominantly  Muslim"  while strong  for child mortality,  is only insignificantly
associated  with higher infant mortality. This pattern of higher child mortality  is consistent  with
the pattern of higher  mortality  for girls aged 14 in some Muslim  countries  such as Pakistan  and
Egypt  (Filmer,  King, and Pritchett, 1997). The exact  causal  mechanisms  behind  either  of these
relationships  have yet to be fully investigated.
"  Mathematically,  if one has a monotonically  increasing  (f  0) but concave  function
f'<O) function  then Jensen's inequality  implies  that  (x)  g  j(x)but there is some  value x
such that  Aix  *)  = f(x).  The difference  between  the two depends  on the distribution  of x, g(x)
such  that mean preserving  spreads  in g(x) increase  the distance  between  the two. In the particular
case of using the log of income  the second  order Taylor  series  expansion  gives the difference
between  the average  of In incomes  and the In of average  incomes as:  l(y)  = !( y 7)+  ap22+R
The difference  between  the average  of the logs and the log of the averages  is sometimes  defined
as an index of inequality.
16 For a formal  discussion  of this issue, as well as a proof that an inequality  measure
adequately  corrects  for the mis-specification,  see Heerink  and Folmer  (1994).
13Ethnolinguistic  fractionalization,  which is defined  as the probability  any two individuals
are not from the same ethnolinguistic  group, is associated  with higher mortality. For instance,
moving  from the level in Costa  Rica (0.07)  to that of Bolivia (0.70)  is associated  with a rise in
mortality  of about 40 percent. This result is new  to the literature,  but perhaps  not surprising. It
is well  known  that in many, although  certainly  not all, instances  ethnolinguistic  minorities  have
worse socioeconomic  outcomes  than the majority  group. With a disadvantaged  minority,  the
larger the group  the higher the fractionalization  and the higher the average  mortality  levels.
Moreover,  there is accumulating  evidence  that political  fractionalization  of all kinds, including
that occasioned  by ethnic conflict,  makes it more difficult  to achieve  desirable  outcomes
(Alesina,  Baqir,  and Easterly 1997).
Perhaps  surprisingly,  some  variables  thought  to be important,  such as the percent  of the
population  that is urban,  whether  the country  is "tropical"  (where  populations  are more exposed
to certain  diseases)  and most surprising,  the percent  of the population  with access  to safe water
are not found to have significant  explanatory  power for under-5  mortality. However,  these
estimates  are conditional  on the other variables  in the regression  (particularly  income)  and hence
there may  be only small amounts  of independent  variation  to identify  these effects.''
Outliers. The results in Table 1 can be used  to define  the "outliers,"  countries  with
under-5  mortality  very different  from the predicted  level based  on observed  non-health  policy
characteristics.  The examination  of outliers  has been  a popular  mode of argumentation  for the
" The correlations  between each  variable  and (the natural  log of) GDP per capita  are in
Appendix  Table  A2-1.
14importance  of health  policy,  and is still used to motivate  discussions  of health policy strategy
(Jamison  and Murray, 1997,  World  Bank, 1997a). There are two interesting  points.
First, the ranking  of countries  depends  heavily  on factors  besides  income. Table 3
presents  the "ten best" and "ten worst" countries  from the "income  alone" (I) and the "income
plus other variables"  (II) regressions  in Table 1. Since  the variables  in addition  to income  add
considerable  explanatory  power,  it is not surprising  the regressions  identify  different  outliers.
Among  the "ten best" countries  from (I), only five reappear  in the "ten best" list for (II) (Jamaica,
Sri Lanka,  Costa  Rica, Singapore,  and Trinidad  and Tobago). Similarly  only five of the "ten
worst"  countries  identified  with income  alone reappear  in the "ten worst" list for the full
regression  (Indonesia,  Mozambique,  Peru, Brazil,  and Bolivia). Income  alone clearly  does not
allow the identification  of countries  that are doing well  (or poorly) with respect  to mortality  in a
way that can be used to identify  good or bad health  policies.
Second,  the difference  in public  spending  on health between  the "ten best" and the "ten
worst" is very small,  while the differences  in public  spending  among  countries  within the "ten
best" or "ten worst" groups  are very large. The average  fraction  of GDP devoted  to public
spending  on health among  the "ten best" is 2.04 percent,  versus  an only slightly lower  average  of
1.81  percent  among  the "ten worst".  Jamaica,  with mortality  80 percent better  than predicted
spends  2.89 percent of GDP while  Brazil, with mortality  almost 50 percent worse than  predicted,
spends  2.97 percent. Sri Lanka,  the second best, spends 1.67  percent  compared  to South Korea,
which spends 1.88  percent. These  are stark examples  of the similarities. Within the "ten best"
and "ten worst" groups  there  are large variations  in the public  sector health spending  as a share  of
15GDP. Costa Rica  does well and has public spending  of 7.5 percent of GDP while Sri Lanka  and
Jamaica  do well spending  only 2.89 and 1.67  percent of GDP respectively.
Table  3: Ten best and  ten worst  from residuals  of under-5  mortality  regressions
Specification  1  II
Description  of  Income  only  Full  regression,  excluding  public  health  expenditures  as a
specification  (Table 1, column 1)  share  of GDP (Table 1, column  2)
Country  Country  Residual  Under-5  Pub  hlth
mortality  exp
rate  %GDP
Best  ten  Israel  Jarnaica  -.795  20  2.896
Jamaica  SriLanka  -.519  35  1.673
Sri Lanka  Costa Rica  -.463  22  7.494
Hong Kong  Singapore  -.451  9  0.985
Costa Rica  CAR.  -.419  169  0.954
Singapore  Kenya  -.416  108  1.647
China  Zaire'  -.375  200  0.180
Panama  Trinidad  and Tobago  -.370  17  2.735
Mauritius  Ethiopia'  -.364  220  0.839
Trinidad  and  Tobago  Myanmar'  -.357  88  1.045
Mean  (unweighted)  2.045
Worst  ten  Sierra Leone  Philippines  .421  69  0.760
Indonesia  Mozambique'  .432  297  4.385
Mozambique  Bangladesh*  .443  180  1.072
Peru  Syria'  .461  59  n/a
Brazil  Bolivia  .461  160  1.599
Laos  Peru  .502  116  1.200
Bolivia  Brazil  .509.  83  2.971
Saudi  Arabia  Indonesia  .634  97  0.571
Namibia  Rwanda  .807  198  1.891
Turkey  Korea  (South)  1.12  30  1.883
Mean (unweighted)  1.815
Notes:  Missing  values  (with dummy  variable  flags)  in the regression  for (+) inequality  (-)  female  education  (*)
ethnolinguistic  fractionalization.
IX Public  spending  on health
How much of the cross-national  difference  in under-5  mortality  can by explained  by
differences  in public  sector health  expenditures? In order to answer  this question,  we use a
16recently  compiled  data set of country  level health  expenditures. The data are the latest available
update  of those  which appear  in World Bank  (1993)  and were prepared  for World  Bank
(1  997a).  8 Table  4, colurmn  I shows  the results  of adding  the (natural  log of) public  sector health
expenditures  as a share of GDP into the regression. Public expenditures  on health do reduce
under-5  mortality,  although  the effect is empirically  small and imprecisely  estimated,  and is
statistically  significant  only at the 10  percent level." 9 Public spending  on health  explains very
little of the variation  in under-S  mortality  over and above  that which can be explained  by non
health-sector  variables,  the incremental  R-squared  is equal to 0.0015.20  This means  that only
0.15 percent  of all mortality  variations  are explained  by differences  in spending. Introducing
public  sector health  expenditures  does not affect  the other coefficients  in the regression  by much
even though it is positively  correlated  with some, particularly  GDP per capita. 2'
1  The sources for the updates  are primarily  country  sources,  e.g. ministries  of health.
'9 We have included  the log of "public  spending  on health as a share of GDP" as derived
from the aggregate  "health production  function"  discussed  below. Using  the log of "public
spending  on health  per capita" yields  the same  point estimate  and signifcance for the effect of
public spending  on health (as a mathematical  re-shuffling  would  show). The only difference  in
the latter specification  is the coefficient  on income.
20  The incremental  R-squared  is generally  not appropriate  as a statistical  procedure  for
resolving  questions  about the relative  importance  of variables,  but if one has prior non-statistical
knowledge  about  the causal  ordering  among  the independent  variables  it is appropriate.
21 In the data set the bivariate  correlation  coefficient  between  GDP per capita and public
sector health expenditures  as a share of GDP is 0.63.
17Table  4: Dependent  variables:  Under-5  or infant  mortality  rate (natural  log)
Column:  I  2  3  4
Dependent  variable  Under-5  Mortality  Rate  Infant  M.R
Method  OLS  Median-  Two-stage  least  Two-stage  least
regression  squares  squares
GDP per capita  (In)  -.611  -.570  -.596+  -.511+
(9.71)  (4.58)  (3.67)  (3.39)
Public health expend.  (In  -.135  -.090  -. 192+  -.078+
of share of GDP)  (1.78)  (0.677)  (.742)  (.243)
Female  -.093  -.076  -.091  -.061
education  (3.54)  (1.65)  (2.90)  (1.63)
Income  .008  .010  .008  .004
inequality  (1.28)  (.91  1)  (1.17)  (.603)
Percent  .001  .001  .001  .001
urban  (.459)  (.190)  (.219)  (.359)
Predominantly  Muslim  .450  .265  .446  .104
(3.18)  (.803)  (2.91)  (.644)
Ethnolinguistic  .549  .303  .534  .343
fractionalization  (3.43)  (1.04)  (2.90)  (1.64)
Tropical  -.051  -.038  -.059  -.165
country  (.549)  (.183)  (.619)  (1.42)
Access  to safe  water  -.001  -.001  -.001  -.003
(.606)  (.140)  (.390)  (.753)
Additional  variables  Dummy  variables  Dummy  variables  for area and a constant  term. Dummy
for area and a  variables  for when female  education,  income  inequality,
constant  term.  ethnolinguistic  fractionalization,  or access  to safe water are
missing.
R-Squared  .9469  .7839*  .9465  .9361
Number  of obs.  98  100  98  98
Notes. Countries  with largest  influence  on parameter  vector  in OLS case and hence  dropped  are for columns  (I)
and (3) Zaire and Korea  (South),  and for column  (4) Israel  and Turkey.
The R-squared  in column  2 is the pseudo  R-squared  calculated  as I minus  the ratio of the sum of absolute
deviations  from  the predicted  median  to those from  the actual median.
'Instruments  are, neighbors' public  health spending,  neighbors'  military  spending,  whether or not the country's
main  export is oil, years since 1776  that  the country  has been  independent,  neighbors' average  local  health
services  (column  4), and neighbors' average  access  to local health  services  (column  5).
-T-statistics  derived  from bootstrapping  with 100  iterations.
18Are these results on public spending on health reliable?  The results on public spending
are not unexpected  as the small  difference  in public  sector health  spending  between  the best and
worst  "outliers"  in Table  3 strongly  hinted  that it was unlikely  to have empirically  large effects.
Empirical  studies  that include  health  resource variables,  such as physicians,  nurses,  or hospital
beds per capita rarely find large and significant  impacts  (Kim and Moody, 1992). There have
been very few previous  estimates  of the impact  of public  spending  in developing  countries,
mostly  because  of the lack  of data, but what there is Musgrove  (1996) summarizes:  "multivariate
estimates  of the determinants  of child mortality  give much  the same answer:  income  is always
significant,  but the health share  in GDP, the public  share  in health  spending,  and the share  of
public  spending  on health in GDP never are."  22
T-hree  studies  find a significant  impact  of public  spending  (these are Anand  and
Ravallion,  1993,  Bidani  and Ravallion,  1997,  and Jarnison  et al, 1996). Anand  and Ravallion
(1993)  themselves  warn that "[a] number  of caveats should  be noted about these results. 1)  They
are based  only on the patterns  observed  in this sample  of 22 countries." As we emphasize  below
the impact  of public  spending  on health is not an immutable  parameter,  but is likely  to vary
widely  from country  to country  and hence the results  may be sensitive  to the sample  used.
Bidani  and Ravallion  (1997)  use a particular  functional  form to desegregate  the impact  of various
variables  into its impact  on the poor and non-poor. They consistently  find an impact  of public
spending  for the poor but not for the non-poor  and their findings  are consistent  with a small or
22  There is a larger literature  in developed  countries,  which also tends  to find little impact
of health  spending,  with some  exceptions  (Wolfe, 1986).
19insignificant  impact  of spending  on aggregate  health status. 23 But their findings  highlight  the
importance  of considering  the incidence  of the health benefits:  they benefit (at best) only the
poor so cuts without  reallocation  would  fall on the poor. As explored  below the impact  on the
poor versus the non-poor  is not a constant  or immutable  parameter,  but depends  on the
composition  and efficacy  of public  spending. Jamison  et al (1996)  use an unusual  econometric
procedure  and find that public spending  on health  lowers  mortality  in their sample of Latin
American  countries. 24 When  we attempt  to replicate  their finding  using our regressions  and
limiting  them to only Latin  America,  we find a positive  and significant  impact  of public spending
on health  if only income is included. However,  adding  our non-income  control  variables  reduces
the magnitude  of the estimate  by half (and it is becomes  statistically  insignificant)."
23 For infant mortality  they  find that the elasticity  at the population  weighted  means is -
0.213 for the poor and -0.056 for the non-poor,  which is roughly  comparable  to our -0.078  in the
aggregate.
24 Jamison  et al (1996)  use a panel of data from 1960  to 1990  to first estimate  (the natural
log of) under 5 mortality  as a function  of income  and year (and interactions)  and whether  the
country  was Latin  American  for a broad  cross section  of countries. They  then use the anti-log  of
the predicted  values to create  a percentage  deviation  of the level of the actual and predicted  for
each country  and then regress  those  percentage  deviations  on the public  and private share  of
health in GDP for the sub-sample  of Latin  American  countries.
25 The regression  with  just income  has an R-squared  of .6474 and estimates  (t-statistics)
for the sample  of 21 countries:
In(uS) = -.70S In(GNPpc) - .464 InPHS
(5.3)  (3.7)
The regression  which includes  our non-income  control variables  has an R-squared  of .8467  and
estimates  (t-statistics)  for the sample  of 21 countries:
ln(uS)  = -.759 ln(GNPpc) .247  InPHS  + .144  FemEd  + .018  Gini  - .247  Urb + .967  Ethno  *.026  Trop- .004  AcSaWa
(3.2)  (1.2)  (2.0)  (.87)  (1.9)  (1.6)  (.04)  (.76)
20Before  we move  on to interpretation,  there are several  questions  about the econometric
validity  of our (and previous)  results that need to be addressed:  robustness,  measurement  error,
and reverse  causation.
First, are the results on public  sector health  spending  driven by a few outlying
observations  or are they robust? First, in the OLS regressions  the two observations  with the
largest  impact  on the parameter  vector  are deleted  to avoid this problem. Second,  the results of
using a median  regression  estimation,  which is much less sensitive  to influential  observations
than  OLS, are shown  in column  2 of table 4.26  The estimated  impact  of health  spending  is
similar  (but smaller  -0.09 versus -0.13)  and the biggest  change  is in the statistical  significance  of
the estimates  (the t-statistic  is only .67 versus 1.78)  but this is perhaps  not too surprising  as OLS
is the more efficient  estimator.
Second,  reverse  causation  and measurement  error are serious  sources  of bias in estimating
the impact  of public  sector expenditures.  If countries  that would otherwise  have high under-5
mortality  devote  larger amounts  to public  health  sector spending  in order  to reduce  mortality  then
the regression  coefficient  could be small,  or even  negative, and still be consistent  with a powerful
positive  impact  of public spending. Measurement  error certainly  exists  because  the accounting
systems  which  track public  spending  on health  are not coordinated  across countries  and therefore
different  countries  are measuring  different  concepts.  An instrumental  variables  estimation
26 Median  regression  is equivalent  to choosing  the parameter  vector in order  to minimize
the sum of absolute  deviations  (as opposed  to the sum of squared  deviations  as is the case  in
OLS). Median regression  is less sensitive  than OLS to influential  observations  as any
deviation  from the regression  line is "weighted" by the absolute value of the deviation,  not the
square of the deviation.
21procedure  potentially  solves  both of these problems. This is the case if the instruments  are
correlated  with the public  sector health spending,  but not correlated  with under-S  mortality
except  through  spending,  and the measurement  error in the instruments  is uncorrelated  with that
in public  sector  spending  on health. As instruments,  we use the average  public  sector  health
spending  as a share  of GDP and the average  defense  spending  as a share  of GDP of a country's
geographic  neighbors.
The two-stage  least squares  results presented  in Table  4, column  3, are similar  to the OLS
results.  The coefficient  on public  sector health  spending  is approximately  40 percent larger  (in
absolute  terms),  -.192 versus -.135, which is consistent  with the OLS estimate being  biased
towards  zero  due to measurement  error. However,  the coefficient  is now much more imprecisely
measured  and statistically  insignificant  from zero  (t-statistic  of only .742). This is a typical
"good news-bad  news" result from instrumental  variables  estimation  as those who would  want to
argue for a large effect  of public  spending  have a higher point  estimate to support  their case,
whereas  skeptics  can point to the very low significance  level.
A third  test for the "robustness"  of our results  is to use an alternative  outcome  measure
for health status. The results in Table 4, column  4 show  that when infant mortality  is used (and
with our "preferred"  two-stage  least squares  estimation)  the results  are again similar,  although
the coefficient  on public  sector health spending  is smaller,  which is consistent  with the higher
"genetic"  component  of neo-natal  deaths (Rutstein,  1984),  and statistically  not significantly
different  from zero.
As an additional  check we reproduced  our results  on a different  data set constructed
directly  from the World  Bank's Social  Indicators  of Development  1997  database  (World  Bank,
221997b). For the 173  countries  that have data on under-5  mortality  and World Bank atlas method
GNP per capita  in US dollars  (which  is not purchasing-power-adjusted),  the explanatory  power
of the regression  which includes  variables  similar  to those  presented  above, is about 90 percent.
The coefficient  on income in this auxiliary  regression  is -0.39 which  is a smaller  effect than we
found. This is partly explained  by the fact that non purchasing-power-adjusted  estimates
systematically  underestimate  the incomes  of poorer  countries  which would  bias the estimate
towards zero. In addition,  random  measurement  error may cause  a bias towards zero. When
using  purchasing-power-adjusted  GDP per capita (from  the Penn World Tables  database)  as an
instrument  for GNP per capita with the set of countries  included  in our main analysis,  over 92
percent  of the variation  is explained,  and the coefficient  rises (in absolute  value) to -0.49.
Including  the reported  public  spending  on health as a share  of GDP produces  a point estimate  of -
0.07 (t-statistic  of .92) for the 1  19 countries  for which the relationship  can be estimated."
Cost of averting a death: Macro and medical estimates.  Overall, these regressions show
that differences  in public  sector  spending  on health  do not go far in explaining  why some
27 The OLS  regression  has an R-squared  on .9095 and estimates  (t-statistics) for the
sample  of 175  countries:
ln(u5)  = -.387 In(GNPpc)  + .008  Fcmillit  + .012  Gini - .001 Urb - .003 AcSaWa
(13.2)  (3.9)  (2.4)  (.64)  (1.9)
The regression  which  includes  public  sector health  spending  as a share of GDP has an R-squared
of .9234 and estimates  (t-statistics)  for the samnple  of 119  countries:
In(uS)  = -.412 In(GNPpc)  + .008 Femillit + .014  Gini-  .001  Urb -.001 AcSaWa  -.073 InPHS
(12.0)  (3.4)  (2.8)  (.23)  (.54)  (.92)
The two-stage  least squares  regression  has an R-squared  of .9215 and estimates  (t-statistics)  for
the sample  of 103  countries  that are in our analysis:
In(uS)  -.492 In(GNPpc)  + .008 Femillit + .014  Gini + .002  Urb - .002  AcSaWa
(6.6)  (2.6)  (2.2)  (.73)  (.65)
All of these include  dummy  variables  for when urban  and access to safe water are missing,  as
well as dummies  for area.
23countries  have  high, and others low, child  mortality.  Doubling  the share  of GDP from the mean
of 2.96 to 5.92  percent would  improve  mortality  by only between  9 (OLS) to 13 (2SLS)  percent.
These results  can be used to calculate  the effect  on health status  of an increase  in public
expenditures.  In order to motivate  this, think  of the specification  of the regressions  in Table  4
columns I through  3 as being  generated  from the following  simple  model  of the determination  of
aggregate  health  status
H,  NH,  A
Health Status,  =  (_  )a  *(1  _  )  *eA'  (1)
where  H, is public  expenditures  in the health sector of country i, NH is the "rest of GDP" (and
includes  all non-public  sector health  spending),  N is the population,  and A is a country  specific
factor. Dividing  the numerators  and denominators  through  by GDP and taking logs implies
ln(Health Status,)  = a  In(  '  )  + P In(  )  + (a  + f3)  In(  GDP,)  + A,
GDP,  GDP,  NI
that is the log of health status is a function  of the log of the public  health  expenditures  as a share
of GDP, non-public  health  sector spending  as a share  of GDP (i.e. with H+NH=GDP),  GDP per
capita, and the country  specific  factor. Allowing  A, to depend  on the a set of observable  and
unobservable  characteristics  leads  to the regression  estimations  reported in
Table 4.28
23 Because  H and NH  spending  add to GDP, 0 in this equation  would  be identified  solely
through  the non-linearity  induced  by taking logs. We therefore  exclude  the share  of non-health
24Equation  (I) implies  an expression  for the relationship  between  the public  expenditures
on health as a share  of GDP and health  status, that is:
a(Health Status,)  (Health Status,)  a
a(HIGDP,)  (GDPIN,)  (H/GDP,)
The above  relationship  can be expressed  in terns of the number  of deaths averted  and, in turn,
can be inverted  to derive the public sector  health  spending  per additional  death averted. An
equivalent  expression  can be derived  for the amount  of GDP that is not public  expenditures  on
health. From the difference  one can calculate  the amount  that would  need to be transferred  from
GDP  to public  sector health  expenditures  in order  to avert an additional  death. The values
derived  from these calculations,  estimated  at the median characteristics  of countries  with under-5
mortality  rates  greater than  20 are presented  in Table  5.29
These  results imply that the cost of averting  the death of a child under-5,  in terms of
public  sector  health spending,  is equal to $47,112  using  the two-stage  least squares  point
estimate. The range of the three  different  estimation  techniques  (two-stage  least squares,  OLS,
spending  from the regressions. When we include  it, and impose  the restriction  that the
coefficient  on health and non-health  sum to the coefficient  on GDP per capita, the results are
extremely  similar. For simplicity  however,  we exclude  it, and infer  the value of the coefficient
on the share  of non-health  spending  ex-post.
29 The calculations  are made for a country with an under-5  mortality rate of 126, a
population  of about 7 million, a GDP per capita of $1,816 (in 1985 international  dollars), a
crude birth rate of 34.15, and whose public health  expenditures  are 2.1 percent of GDP.
25median regression) is $47,112 to $100,927.  The amount for non-health spending is between
$863,000 and $1 million. 30
Table 5: Cost of averting  a death derived  from different  specifications  of health status regressions.
Source  of estimate  of a  Value  of  Increasing  Transferring  Increasing  non-
[coefficient  on ln(share  of  a  public  expenditures  health  GDP
public  health  in GDP)]  (13)  expenditures  from  non-
on  health  health  to health
Two-stage  least  squares  -.1917
(-.4044)  47,112  49,381  1,025,398
OLS  -.1354
(-.4756)  66,680  72,202  871,894
Median  regression  -.0895
(-.4805)  100,850  114,193  863,107
The highest fraction of deaths, and in particular of child deaths, in developing countries
are due to infectious and parasitic diseases (such as diarrheal diseases, TB, or malaria). As
reported  in Table  6, about 28 percent  of all deaths in developing  countries  are due to infectious
and parasitic  diseases  among  children  under-5. The two most prominent  among  those  are
children  under-5  dying of diarrheal  diseases  and Acute Respiratory  Infections  (ARI)  which  each
account  for slightly  over 10 percent  of all deaths. An additional  8 percent  of all deaths in
30Our confidence  in these method  for producing  reasonable  magnitudes  is bolstered  by
the fact that Vicusi  (1993)  reports  the estimated  individual  "willingness  to pay" to avert a
statistical  death for the United  States. The range of estimates  is very wide, between  $2.5 and
$7.3 million  which  is between 124  and 375 times the average  workers' income. There  are few
studies like this for developing  countries,  but a hedonic  wage regression  for Taiwan,  China, gives
an estimate  of $650,000  which is 54 times average  worker  income (assuming  GDP per capita is
half average  worker income). If we view the "non-public  health share" part of our estimates  to
be related  to private  expenditures  on health, then our estimate from the two-stage  least squares
estimate is $1 million, or 265 times the average  worker income  of the countries  under study
(again  assuming  GDP per capita is half average worker income)  which is lower than the US
range but higher than the Taiwanese  estimates, but in both cases within a small multiple.
26developing countries are due to perinatal conditions.  Since these are the largest causes of death,
a substantial reduction in overall mortality must involve a fall in mortality from these causes.
Table 6: Percent  of deaths  by cause for population  subgroups  and cost per death averted
Percent  of deaths by cause  Estimates  of cost per death
(Estimates  for 1985)  averted of treatment
Indust.  mkt.  Developing  countries  Developing  countries
economies
All ages  All Ages  Under-5
Infectious  and parasitic  4.6  44.9  27.7
Diarrheal  Diseases  0.0  13.2  10.6  $ 1000  - $ 10,000'
Tuberculosis  0.2  7.9  0.8  $ 20 - $ 76b
ARI  3.6  16.6  11.3  $379-$  1,610'
Non-ARI measlesand  0.0  1.8  1.8  $ 10- $ 561l
whooping cough  _  l_l
Malaria  0.0  2.6  2.0  $ 78 - $ 9904
Other  0.0  2.6  1.2
Compl.  of pregnancy  0.0  1.3  0.0  $836-$3,967'
Perinatal  conditions  0.6  8.4  8.4
Non-communicable  78.6  29.8  0.0
External  (incl. injuries)  17.0  15.6  2.4
Total  100  100  38.5
Source:  Causes  of  death  calculated  from  Lopez  (1993),  sources  for  costs  are Diarrheal-Martines  and  others
(1993),  TB-Murray  and  others  (1993),  ARI-Stansfield  and  Shepard  (1993),  Measles-Foster  and others  (1993),
Malaria-Najera  and  others  (1993).
Notes:  a) Current  US  dollars,  from  model  estimates,  b) 1989  US  dollars,  from  3 Sub-Saharan  African  countries
(Malawi,  Mozarnbique,  and  Tanzania),  c) Current  US  dollars,  from  model  estimates,  measles  only,  d) Malaria
control,  1987  US  dollars,  from  2 studies,  I in Sri  Lanka  ($78)  using  insecticides,  one for  Developing  countries
($990)  using  vector  control,  e) Current  US  dollars,  from  model  estimates,  matemal  and  no-natal  deaths  are  not
distinguished  in this  study.
27A selected  group of estimates  of the cost per death averted  for a variety of treatments  that
address  these conditions  are presented  in Table  6 (derived from Jamison  and others, 1993). The
cost of averting  a death by treating  each of the conditions  are estimated  using different  methods
(e.g. model  estimates  versus  observed  ranges) and should  be used with extreme  caution. The
ranges  for the three biggest  killers  are $1,000-$  10,000  for diarrheal  diseases,  and a much  more
modest  $379-$1,610  for ARI  and $836-$3,967  for the complications  of pregnancy. From these
numbers  it would  appear  that public  sector  intervention  to treat each of these conditions  could be
done relatively  cheaply  and could save many lives.
III) How to reconcile  the apparent  and actual performance  of public spending
The results discussed  so far imply that between  the "effectiveness"  of public  spending  on
health  and the "cost effectiveness"  of available  medical  interventions  there is a several  orders  of
magnitude  gap in the cost per averting  a child death. The cross-national  regression  results
suggest  a range between  about $50,000  and $100,000  whereas  the medical  intervention  cost
effectiveness  figures  suggest  a range between  $10  and $4000  (excluding  the upper limit  of
$10,000  on diarrheal  diseases). Understanding  why public  spending  on health  has not had a
strong  effect on reducing  mortality  is crucial  to designing  public  policy  to reduce  excess
mortality  and morbidity  in developing  countries. In this section  we present  only an outline of the
analytical  possibilities. A detailed  exploration,  including  a review  of the existing  empirical
literature,  is contained  in a companion  paper (Filmer,  Hammer,  and Pritchett, 1997).
What is of interest  is the impact  of spending  an additional  public  dollar on health status,
or the total derivative  of health  status  with respect  to public  spending. This total derivative  can
28be analytically  broken  into three components,  through  a chain of partial derivatives,  summarized
in Figure 1:
*  Health  production  function. The change  in health status is affected  as a proximate
matter by changes  in the consumption  of various  health services  some of which  are more,
and some  less, effective  in improving  health.
*  Net public sector impact.  However,  even of particular  services that  are "cost effective"
in improving  health,  this does not mean that  public spending  on those goods would  be
cost effective  in improving  health,  as additional  consumption  in the public  sector
occasioned  by public  supply  will crowd  out, to differing  extents,  services  that would  have
been consumed  anyway. So the second  term is the change in the consumption  of health
services  (of various  kinds)  occasioned  by an expansion  in effective  public  supply  of those
services.
* Public  sector efficacy. Moreover,  the impact  of public spending  will depend  first on
the degree  to which  public spending  is able to create effective  public services. That is, in
some countries  a dollar spent  in the public  sector on health will create facilities  and
services  which  are effective  at improving  health status  while in other countries  it will
create no services  at all.
Since the total impact  of public sector  spending  is the product  of these three terms, if any one of
them is low the total impact  will be low. This framework  provides  a useful way of summarizing
the differing  conclusions  and policy  reformn  implications  that various schools  of thought  and
analysts  draw from the typically  low effectiveness  of public spending.
29I Medical intervention cost-effectiveness (MICE) ofpubliclyfinanced  health services.  Far
and away  the most widely  held interpretation  is that the composition  of public  spending  across
types  of medical  services  and levels of medical facilities  accounts  for the typical  low efficacy  of
public  spending  and a better  allocation  of spending  accounts  for the successes. In this
interpretation,  the reason  why public  spending  on health  has not produced  health gains  is that the
bulk of public  monies  are spent  on high cost curative  services  at facilities  that are more complex
than necessary. This,  to a large extent, is the common  intellectual  impetus behind  Primary
Health  Care (PHC)  and the "basic package"  based on MICE  as approaches  to health strategy,
which  are mainly  relevant  to low income  countries,  and to reforms  to limit cost escalation  (again
based  on MICE),  which is relevant  to the higher income  countries. While  this is logically
possible,  and while  it is easy to demonstrate  that evaluated  on MICE  grounds  primary  treatments
like ORT or vaccinations  are better than some  types of heart surgery,  the evidence  for this
strategy  is still more  deduced  than demonstrated. While  some  of the "good outliers" certainly
have something  like  a PHC strategy,  it has not been demonstrated  that any large significant
fraction  of the differences  in either the health performance  or efficiency  in health  spending  across
countries  is due to the composition  of health spending.
Markets, market failures, and public interventions in health.  A second school of thought
suggests  that what is relevant  to the efficacy  of public  spending  on health  is not the composition
of public spending  on health  services  evaluated  on MICE  grounds,  but evaluated  by their
economic  characteristics.  Various health interventions  have different  economic  properties:  some
are public  goods  (vector  control,  traditional  public health  activities),  some  are private  goods with
little or no externalities  (most curative  services),  while others  are mostly  private  goods but with
30substantial  externalities  (infectious  diseases  activities,  vaccinations). The actual impact  of the
public  provision  of any given service  on health  status is not measured  by its effectiveness
evaluated  as a medical  intervention,  with and without  the treatment,  but by the difference  in
outcomes  with and without  the  public sector intervention. Taking  an aspirin  when you have  a
headache  might be a health  intervention  with high MICE,  but public spending  on aspirin  is
unlikely  to be effective  because  it mostly  displaces  private spending  and hence would not
actually  reduce  the number  of headaches. Vector  control,  on the other hand, might be much less
effective  than aspirin  evaluated  by MICE,  but since  vector  control is a public good it is possible
there would  have been little  or none in the absence  of public  sector  action so this intervention
might score high in Public Sector Cost Effectiveness  (PSCE). The difference  between  MICE  and
PSCE depends  on both the demand  and the supply for particular  health services,  which will
certainly  vary not only across  services  but also from location  to location,  even within countries.
Once it is acknowledged  that the consumption  of health services  is based  on individual
choices,  it is possible  that mortality  is primarily  determined  by individuals'  incomes and
education,  and that it is therefore  not very sensitive  to the "price"  (by which  we mean the total
cost, including  access,  travel, and waiting)  of health  services,  which  is what might be influenced
by the availability  of clinical  services  through  the public  sector. Moreover,  if private (profit and
non-profit)  entities  are allowed  to supply  health services,  then public  sector spending  is even less
likely  to have  a large effect  on aggregate  mortality. In this case,  public spending  determines  the
composition  of spending  between  the public and private  sectors,  but not health  outcomes  (Filmer,
Hammer,  and Pritchett, 1997).
31One  might question  why we do not therefore  estimate health  status as a function  of
private  expenditures  on health. There are two reasons. First, when private  expenditures
decisions  are voluntarily  made then, in choosing  to spend,  people at least believe  they will
receive  value for money. But this active choice  makes private  expenditures  certainly,  and
perhaps  irredeemably,  endogenous  and it is very difficult  to separate  out the impact  of
expenditures  on health  status from health  status  on expenditures. 3'  Second,  the best the data  can
give  is total expenditures  on health,  but cannot  decompose  total expenditures  into prices and
quantities  so there is no way of identifying  the impact  of increased  quantities  of privately
purchased  health  services. Suppose  for instance  that the only private health  expenditure  was on
penicillin,  that the use of penicillin  had a beneficial  effect  on stopping  child deaths,  and that the
demand  for penicillin  was very unresponsive  to price. Then suppose  one country  imported  the
drug  at a low price while the other imposed  a large tariff that raised  the domestic  prices. In this
case  private  expenditures  would  have  negative  correlation  with health  status  as higher prices
would  lead  to a lower quantity  consumed  and hence worse mortality  outcomes,  even though  total
expenditures  could  be higher. Therefore  any cross-national  regression  between  private
expenditures  and health  status has no obvious  interpretation.
Public  sector reform. Finally,  there is a third school of thought. This school argues  that
it is not so much the announced  strategy  of the government,  but how well  the government
actually  performs  that determines  the impact  of public spending. This interpretation  points to the
poor quality,  low  utilization,  high unit costs, and medical  ineffectiveness  of public  sector health
31 Policy decisions  regarding  health spending are more exogenous  and hence these
factors can be separated  out for public sector health spending.
32facilities  in many  countries.  If whatever  services  the facilities  were intended  to provide  are not
available  then neither  theirpotential  MICE  or their  potential PSCE matter. When  the penicillin
intended  for a rural clinic has been resold  on the black market  then the question  of the relative
effectiveness  of public spending  on various  kinds of treatments  seems  academic,  at best. The
estimated  impact  of health spending  might be low because  the efficacy  of the public  sector  varies
so widely  across  countries.
Of course  these three schools  of thought  are not mutually exclusive  and, by construction
of the framework,  all three matter. The hard question  for public  policy is their relative  empirical
importance  in any given situation. In some cases  the government  may be quite effective  at
supplying  services  and the private market  weak  (for example  in inaccessible,  poor rural areas).
In others  cases  the government  may be quite ineffective  and the private sector strong. In some
cases  the market  for inexpensive  curative  services  (of a PHC)  type may work quite well while
elsewhere  insurance  markets  are weak  so public  sector supply  of tertiary  services  makes  the most
sense.
Concluss
The results presented  in this paper show  that a remarkable  amount of the cross-country
variation  in health status, as measured  by the under-5  mortality  rate, can be explained  by
variation  in factors  not related  to non-health  sector  policy. Approximately  95 percent  of the
variation  in under-5  mortality  is explained  with income,  its distribution,  female  education,  and
other "cultural"  factors. Moreover,  the results  show  that, although  income alone is a powerful
determinant,  other factors  are significant  determinants  of under-5  mortality.
33In addition,  higher  public spending  on health  as a share  of GDP is shown to be very
tenuously  related  to improved  health status. The observed  efficacy  of public spending  is several
orders  of magnitude  lower  than the apparent  potential.
The correct  interpretation  of the empirical  results  and their policy  implications  depend  on
three factors,  cost effectiveness  ofpublic spending,  the net impact  of additional  public supply,
andpublic sector  efficacy. Each can explain the observed  results and almost certainly  each
contributes  to explaining  the low typical  efficacy  of actual public spending. Each has difference
implications  for reformn  and which  is the most important  depends  on the particular  situation.
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35Appendix 1: Cross  national  data availability  and reliability
This appendix  provides  details  on four  aspects  of the cross national  regressions:  data on health
status,  data on independent  variables,  data on health sector  strategy,  and functional  form.
a) Data on health  status
The data  used here  are as reported  by UNICEF  (1992)  except for the mortality  rates for
Zaire  which are unbelievable:  under-5  mortality  rate for 1990 is reported  as 130  and infant
mortality  rate as 79. These are replaced  with the, more  reliable, estimates  reported in United
Nations  (1992)  for 1984. These are 200 for under-5  mortality  and 126  for infant mortality.
b) Data  on non-health  sector variables
Income  Real GDP per capita in 1995  international  dollars  (i.e. adjusted  for
Purchasing  Power Parity)  are from the Penn World  Tables 5.6.
Education  Average  education  levels for men and women over 15  are from Barro
and Lee (1996).
Income  inequality  Gini coefficient  as calculated  by Deininger  and Squire (1996)  multiplied
by 100.
Percent  urban  Percent  of the country's population  that lives in urban  areas. From the
World  Bank's Social  Indicators  of Development  database.
Predominantly  Dummy  equal to one if over 90 percent  of the country's population  is
Muslim  Muslim.
Ethnolinguistic  Index  of ethnolinguistic  fractionalization  for 1960. Measures  the
fractionalization  probability  that two randomly  selected  people  from a given country  will
not belong  to the same ethnolinguistic  group as reported in Easterly  and
Levine  (1996).
Tropical  country  Dummy  equal to one if part of the country's territory  lies within 20
degrees  of the equator.
Access  to safe  Percent  of population  with access to safe water. From the World
water  Bank's Social  Indicators  of Development  database.
Oil exporter  Dummy  equal to one if the country  primary  export is fuels (mainly  oil)
as classified  by the World  Bank's World  Development  Indicators
(1996)  plus Kuwait.
36Years  independent  The percentage  of years  since 1776  that a country  has been independent,
as reported  in Easterly  and Levine  (1996).
Defense  spending  Defense  spending  as a share  of GDP, as reported in CIA (1994)
c) Data  on health  sector variables
Health  As part of the World  Development  Report 1993, Investing  in Health,
Expenditures  figures  on the magnitude  of health expenditures  were generated
(Murray,  Govindaraj,  and Musgrove,  1995). These have  undergone
various updates,  based  on country  level reports. We use the latest  data
available  in our analysis.
Percentage  of  As reported  in the WHO's Health  for All Database. The observation
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37Table A2-  1: Summary  statistics  for estimation  sample  (Number  of observations  = I  00)
Mean  Std. Dev.  Correlation  with
GDP per capita  (In)
Under-5  mortality  rate (In)  3.928  1.183  -.9274
Under-I mortality  rate  (n)  3.605  1.053  -.9200
GDP  per capita  (In)  7.914  1.151  1.000
Public  health  expend.  (In of share of GDP)  -3.769  .7591  .6228
Female  education  4.971  2.753  .8115
Income  inequality  40.93  8.706  -.2432
Percent  urban  49.96  25.01  .8075
Predominantly  Muslim  .120  .327  .0096
Ethnolinguistic  fractionalization  .4219  .2871  -.5112
Tropical  country  .620  .488  -.6445
Access  to safe water  67.13  25.73  .6909
East  Asia and Pacific  .10  .302  .0377
Latin America  and Caribbean  .21  .409  .0090
Middle  East  and North Africa  .09  .288  .1236
South  Asia  .05  .219  -.1346
Sub-Saharan  Africa  .31  .465  -.6812
Female  education  missing  .11  .314  -.2463
Income  inequality  missing  .23  .423  -.2649
Ethnolinguistic  fractionalization  missing  .08  .273  .0390
Access  to safe water  missing  .08  .273  .3405
Under-5  mortality  rate  87.75  77.25
Under-I mortality  rate  56.96  44.66
GDP per capita  5004  5300
Public  health  expend.  (Share  of GDP)  .02967  .01998
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